|Previous Guidance||Current Guidance|
|Revenues||$1.625B to $1.675B||$1.700B to $1.725B|
|Adjusted diluted earnings per share||$1.55 to $1.60||$1.71 to $1.76|
|Cash flows from operations||$85M to $95M||$120M to $130M|
PharMerica (PMC) is in talks with Bank of America (BAC) and UBS Group (UBS) about exploring strategic alternatives.
Trade-Ideas LLC identified Pharmerica (PMC) as a strong and under the radar candidate
Stocks with insider trader activity include PMC, JAZZ and EA